LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 21

Search options

  1. Article ; Online: Medical Aspects of mTOR Inhibition in Kidney Transplantation.

    Cuadrado-Payán, Elena / Diekmann, Fritz / Cucchiari, David

    International journal of molecular sciences

    2022  Volume 23, Issue 14

    Abstract: The advances in transplant immunosuppression have reduced substantially the incidence of kidney graft rejection. In recent years, the focus has moved from preventing rejection to preventing the long-term consequences of long-standing immunosuppression, ... ...

    Abstract The advances in transplant immunosuppression have reduced substantially the incidence of kidney graft rejection. In recent years, the focus has moved from preventing rejection to preventing the long-term consequences of long-standing immunosuppression, including nephrotoxicity induced by calcineurin inhibitors (CNI), as well as infectious and neoplastic complications. Since the appearance in the late 1990s of mTOR inhibitors (mTORi), these unmet needs in immunosuppression management could be addressed thanks to their benefits (reduced rate of viral infections and cancer). However, management of side effects can be troublesome and hands-on experience is needed. Here, we review all the available information about them. Thanks to all the basic, translational and clinical research achieved in the last twenty years, we now use mTORi as de novo immunosuppression in association with CNI. Another possibility is represented by the conversion of either CNI or mycophenolate (MPA) to an mTORi later on after transplantation in low-risk kidney transplant recipients.
    MeSH term(s) Calcineurin Inhibitors/adverse effects ; Graft Rejection/prevention & control ; Graft Survival ; Immunosuppressive Agents/adverse effects ; Kidney Transplantation/adverse effects ; TOR Serine-Threonine Kinases
    Chemical Substances Calcineurin Inhibitors ; Immunosuppressive Agents ; TOR Serine-Threonine Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2022-07-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23147707
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Safety profile and clinical results of Remdesivir in Hemodialysis patients infected with SARS-CoV-2. A single-center Spanish cohort study.

    Cuadrado-Payán, Elena / Rodríguez-Espinosa, Diana / Broseta, José Jesús / Guillén-Olmos, Elena / Maduell, Francisco

    Journal of nephrology

    2022  Volume 36, Issue 1, Page(s) 171–172

    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19 ; Cohort Studies ; COVID-19 Drug Treatment ; Renal Dialysis/adverse effects ; Antiviral Agents/adverse effects
    Chemical Substances remdesivir (3QKI37EEHE) ; Antiviral Agents
    Language English
    Publishing date 2022-06-18
    Publishing country Italy
    Document type Letter
    ZDB-ID 1093991-x
    ISSN 1724-6059 ; 1120-3625 ; 1121-8428
    ISSN (online) 1724-6059
    ISSN 1120-3625 ; 1121-8428
    DOI 10.1007/s40620-022-01364-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Physiopathological role of extracellular vesicles in alloimmunity and kidney transplantation and their use as biomarkers.

    Cuadrado-Payán, Elena / Ramírez-Bajo, María José / Bañón-Maneus, Elisenda / Rovira, Jordi / Diekmann, Fritz / Revuelta, Ignacio / Cucchiari, David

    Frontiers in immunology

    2023  Volume 14, Page(s) 1154650

    Abstract: Antibody-mediated rejection is the leading cause of kidney graft dysfunction. The process of diagnosing it requires the performance of an invasive biopsy and subsequent histological examination. Early and sensitive biomarkers of graft damage and ... ...

    Abstract Antibody-mediated rejection is the leading cause of kidney graft dysfunction. The process of diagnosing it requires the performance of an invasive biopsy and subsequent histological examination. Early and sensitive biomarkers of graft damage and alloimmunity are needed to identify graft injury and eventually limit the need for a kidney biopsy. Moreover, other scenarios such as delayed graft function or interstitial fibrosis and tubular atrophy face the same problem. In recent years, interest has grown around extracellular vesicles, specifically exosomes actively secreted by immune cells, which are intercellular communicators and have shown biological significance. This review presents their potential as biomarkers in kidney transplantation and alloimmunity.
    MeSH term(s) Kidney Transplantation/adverse effects ; Extracellular Vesicles ; Kidney ; Exosomes ; Biomarkers
    Chemical Substances Biomarkers
    Language English
    Publishing date 2023-08-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1154650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients.

    Rodríguez-Espinosa, Diana / Morantes, Laura / García, Jenmy / Broseta, José Jesús / Cuadrado-Payán, Elena / Colmenero, Jordi / Torregrosa, Josep Vicens / Diekmann, Fritz / Esforzado, Nuria

    Transplantation proceedings

    2024  Volume 56, Issue 2, Page(s) 330–334

    Abstract: Background: The pretransplant diagnosis of liver malignancies in nodular cirrhotic livers remains a diagnostic challenge despite current advances. Although the prognostic impact of incidental hepatocellular carcinoma (HCC) or intrahepatic ... ...

    Abstract Background: The pretransplant diagnosis of liver malignancies in nodular cirrhotic livers remains a diagnostic challenge despite current advances. Although the prognostic impact of incidental hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCC) in liver transplant recipients is well documented, there are no data on the impact in simultaneous liver kidney transplant (LKT) recipients.
    Methods: This is a single-center observational, retrospective study of all LKT performed from May 1993 to April 2022. Among these patients, demographic data, immunosuppressive therapy, rejection episodes, and prevalence of incidental HCC or iCC were evaluated.
    Results: One hundred eight LKTs were performed and 6 were excluded. There were 13 patients with incidental carcinomas in the explanted liver: one of them with both an HCC and iCC, one with an iCC, and the remaining with an HCC. One case of iCC died. No other recurrences occurred. There were no cases of incidental HCC nor iCC in patients with a hereditary or metabolic LKT indication. We found no differences in the 5-year patient survival, and death-censored kidney and liver graft survival rates for those LKT with an incidental HCC and those without it (76.9% vs 84.2%, P = .5; 100% vs 91.6%, P = .28; and 100% vs 94.7%, P = 0.39, respectively). Finally, there were no significant associations between explant carcinoma and rejections of the liver (7.7% vs 17.9%, P = .34) or kidney graft (0% vs 16.8%, P = 0.11).
    Conclusion: Despite a high prevalence of incidental HCC or iCC, patient, kidney, and liver graft 5-year survival were unaffected by incidental HCC.
    MeSH term(s) Humans ; Liver Neoplasms/pathology ; Carcinoma, Hepatocellular/pathology ; Kidney Transplantation/adverse effects ; Retrospective Studies ; Cholangiocarcinoma ; Bile Ducts, Intrahepatic/pathology ; Bile Duct Neoplasms ; Kidney/pathology
    Language English
    Publishing date 2024-02-12
    Publishing country United States
    Document type Observational Study ; Journal Article
    ZDB-ID 82046-5
    ISSN 1873-2623 ; 0041-1345
    ISSN (online) 1873-2623
    ISSN 0041-1345
    DOI 10.1016/j.transproceed.2024.01.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle.

    Forado-Benatar, Ilana / Caravaca-Pérez, Pedro / Rodriguez-Espinosa, Diana / Guzman-Bofarull, Joan / Cuadrado-Payán, Elena / Moayedi, Yasbanoo / Broseta, José Jesús / Farrero, Marta

    Frontiers in cardiovascular medicine

    2023  Volume 10, Page(s) 1255503

    Abstract: There is a growing interest in the evaluation of tricuspid regurgitation due to its increasing prevalence and detrimental impact on clinical outcomes. Historically, it has been coined the "forgotten" defect in the field of valvular heart disease due to ... ...

    Abstract There is a growing interest in the evaluation of tricuspid regurgitation due to its increasing prevalence and detrimental impact on clinical outcomes. Historically, it has been coined the "forgotten" defect in the field of valvular heart disease due to the lack of effective treatments to improve prognosis. However, the development of percutaneous treatment techniques has led to a new era in its management, with promising results and diminished complication risk. In spite of these advances, a comprehensive exploration of the pathophysiological mechanisms is essential to establish clear indications and optimal timing for medical and percutaneous intervention. This review will address the most important aspects related to the diagnosis, pathophysiology and treatment of tricuspid regurgitation from a cardiorenal perspective, with a special emphasis on the interaction between right ventricular dysfunction and the development of hepatorenal congestion.
    Language English
    Publishing date 2023-10-04
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2781496-8
    ISSN 2297-055X
    ISSN 2297-055X
    DOI 10.3389/fcvm.2023.1255503
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits.

    Broseta, José Jesús / Roca, Marta / Rodríguez-Espinosa, Diana / López-Romero, Luis Carlos / Gómez-Bori, Aina / Cuadrado-Payán, Elena / Bea-Granell, Sergio / Devesa-Such, Ramón / Soldevila, Amparo / Sánchez-Pérez, Pilar / Hernández-Jaras, Julio

    Frontiers in physiology

    2022  Volume 13, Page(s) 1013335

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2022-11-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564217-0
    ISSN 1664-042X
    ISSN 1664-042X
    DOI 10.3389/fphys.2022.1013335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism-A Targeted Metabolomics Approach.

    Broseta, José Jesús / Roca, Marta / Rodríguez-Espinosa, Diana / López-Romero, Luis Carlos / Gómez-Bori, Aina / Cuadrado-Payán, Elena / Devesa-Such, Ramón / Soldevila, Amparo / Bea-Granell, Sergio / Sánchez-Pérez, Pilar / Hernández-Jaras, Julio

    International journal of molecular sciences

    2022  Volume 23, Issue 19

    Abstract: Acetate is widely used as a dialysate buffer to avoid the precipitation of bicarbonate salts. However, even at low concentrations that wouldn't surpass the metabolic capacity of the Krebs tricarboxylic acid (TCA) cycle, other metabolic routes are ... ...

    Abstract Acetate is widely used as a dialysate buffer to avoid the precipitation of bicarbonate salts. However, even at low concentrations that wouldn't surpass the metabolic capacity of the Krebs tricarboxylic acid (TCA) cycle, other metabolic routes are activated, leading to undesirable clinical consequences by poorly understood mechanisms. This study aims to add information that could biologically explain the clinical improvements found in patients using citrate dialysate. A unicentric, cross-over, prospective targeted metabolomics study was designed to analyze the differences between two dialysates, one containing 4 mmol/L of acetate (AD) and the other 1 mmol/L of citrate (CD). Fifteen metabolites were studied to investigate changes induced in the TCA cycle, glycolysis, anaerobic metabolism, ketone bodies, and triglyceride and aminoacidic metabolism. Twenty-one patients completed the study. Citrate increased during the dialysis sessions when CD was used, without surpassing normal values. Other differences found in the next TCA cycle steps showed an increased substrate accumulation when using AD. While lactate decreased, pyruvate remained stable, and ketogenesis was boosted during dialysis. Acetylcarnitine and myo-inositol were reduced during dialysis, while glycerol remained constant. Lastly, glutamate and glutarate decreased due to the inhibition of amino acidic degradation. This study raises new hypotheses that need further investigation to understand better the biochemical processes that dialysis and the different dialysate buffers induce in the patient's metabolism.
    MeSH term(s) Acetates/pharmacology ; Acetylcarnitine ; Bicarbonates/pharmacology ; Citrates/pharmacology ; Citric Acid ; Citric Acid Cycle ; Dialysis Solutions/adverse effects ; Glutamates ; Glutarates ; Glycerol ; Humans ; Inositol ; Ketone Bodies ; Lactates ; Prospective Studies ; Pyruvic Acid ; Renal Dialysis/adverse effects ; Salts ; Triglycerides
    Chemical Substances Acetates ; Bicarbonates ; Citrates ; Dialysis Solutions ; Glutamates ; Glutarates ; Ketone Bodies ; Lactates ; Salts ; Triglycerides ; Citric Acid (2968PHW8QP) ; Inositol (4L6452S749) ; Acetylcarnitine (6DH1W9VH8Q) ; Pyruvic Acid (8558G7RUTR) ; Glycerol (PDC6A3C0OX)
    Language English
    Publishing date 2022-10-02
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms231911693
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SARS-CoV-2 and influenza virus co-infection.

    Cuadrado-Payán, Elena / Montagud-Marrahi, Enrique / Torres-Elorza, Manuel / Bodro, Marta / Blasco, Miquel / Poch, Esteban / Soriano, Alex / Piñeiro, Gaston J

    Lancet (London, England)

    2020  Volume 395, Issue 10236, Page(s) e84

    MeSH term(s) Betacoronavirus ; COVID-19 ; China ; Coinfection ; Coronavirus Infections ; Humans ; Inpatients ; Orthomyxoviridae ; Pandemics ; Pneumonia, Viral ; Retrospective Studies ; Risk Factors ; Severe acute respiratory syndrome-related coronavirus ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-05-05
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(20)31052-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Challenges in perioperative blood transfusions in kidney transplantation and the need for Patient Blood Management.

    Rodríguez-Espinosa, Diana / Broseta, José J / Rosario, Anney / Cacho, Judit / Tena, Beatriz / Cuadrado-Payan, Elena / Marrero, Ramsés / Bayés, Beatriu / Esforzado, Nuria / Musquera, Mireia / Diekmann, Fritz / Cases, Aleix / Basora, Misericordia

    Blood transfusion = Trasfusione del sangue

    2023  

    Abstract: Background: Anemia is highly prevalent in end-stage chronic kidney disease patients, increasing their risk of receiving blood transfusions during and on the days after a kidney transplant (KTx) surgery. However, there is currently a lack of data that ... ...

    Abstract Background: Anemia is highly prevalent in end-stage chronic kidney disease patients, increasing their risk of receiving blood transfusions during and on the days after a kidney transplant (KTx) surgery. However, there is currently a lack of data that thoroughly describes this phenomenon in this population, the associated risk factors, and how they could benefit from the application of Patient Blood Management (PBM) guidelines.
    Materials and methods: Observational study. All adult patients who received a KTx between January 1
    Results: We found that a high amount (39%) of KTx recipients required at least one blood transfusion during the perioperative period. And that 1) most of these patients had anemia at the time of transplantation (85.4%), 2) iron status upon admission was associated with the transfusion of more blood units (3.9 vs 2.7, p=0.019), 3) surgical reintervention (OR 7.28, 2.35-22.54) and deceased donor donation (OR 1.99, 1.24-3.21) were associated with an increased risk of transfusion, and finally, 4) there was an association between a higher number of blood units transfused and impaired kidney graft function six months after hospital discharge (1.6 vs 1.9, p=0.02).
    Conclusions: In conclusion, PBM guidelines should be applied to patients on the KTx deceased donor waiting list and especially those scheduled to receive a transplant from a living donor. This could potentially increase the utilization efficiency of blood products and avoid transfusion-related severe adverse effects.
    Language English
    Publishing date 2023-10-09
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2135732-8
    ISSN 2385-2070 ; 0041-1787 ; 1723-2007
    ISSN (online) 2385-2070
    ISSN 0041-1787 ; 1723-2007
    DOI 10.2450/BloodTransfus.577
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection.

    Cacho, Judit / Nicolás, David / Bodro, Marta / Cuadrado-Payán, Elena / Torres-Jaramillo, Verónica / Gonzalez-Rojas, Ángela / Ventura-Aguiar, Pedro / Montagud-Marrahi, Enrique / Herrera, Sabina / Rico, Veronica / Cofàn, Frederic / Oppenheimer, Frederic / Revuelta, Ignacio / Diekmann, Fritz / Cucchiari, David

    Kidney international

    2022  Volume 102, Issue 4, Page(s) 917–921

    MeSH term(s) Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; COVID-19/drug therapy ; Humans ; Kidney Transplantation/adverse effects ; SARS-CoV-2 ; Transplant Recipients
    Chemical Substances remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Alanine (OF5P57N2ZX)
    Language English
    Publishing date 2022-08-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 120573-0
    ISSN 1523-1755 ; 0085-2538
    ISSN (online) 1523-1755
    ISSN 0085-2538
    DOI 10.1016/j.kint.2022.08.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top